Drug intelligence / Profile preview

artemisia absinthium pollen extract

Development stage
Unknown
Lead developer
ALK Abelló
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Intradermal, Subcutaneous, Sublingual, Intranasal
01

Overview

Artemisia absinthium pollen extract is a biological product derived from the pollen of the wormwood plant, used primarily in the field of allergology. It serves a dual purpose: as a diagnostic tool for identifying type I hypersensitivity through skin prick testing and as a therapeutic agent in allergen immunotherapy (AIT). The extract contains a complex mixture of proteins (allergens) that, when introduced to a sensitized individual, cross-link IgE antibodies bound to the high-affinity IgE receptor (FcεRI) on mast cells and basophils, triggering the release of inflammatory mediators. In the context of immunotherapy, repeated exposure to increasing doses of the extract aims to induce immunological tolerance, characterized by a shift from a Th2-dominated allergic response to a Th1/Treg response and the production of blocking IgG4 antibodies.

Brand names
Artemisia Absinthium
Other names
Wormwood pollen extractArtemisia absinthium allergenic extract
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on artemisia absinthium pollen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on artemisia absinthium pollen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call